As of November 2024 CRISPR Therapeutics has a market cap of £3.41 Billion. This makes CRISPR Therapeutics the world's 2963th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 7th, 2024 the market cap of CRISPR Therapeutics was reported to be: